Ładuje się......
Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
We have evaluated the efficacy of dapagliflozin in patients with type 1 diabetes mellitus (DM1) without adequate control. We expected that adding dapagliflozin to this population on top of their base treatment would lower their HbA1c levels. We conducted a pragmatic, open, 24-week study of treatment...
Zapisane w:
| Wydane w: | J Diabetes Metab Disord |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600276/ https://ncbi.nlm.nih.gov/pubmed/26457255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-015-0210-x |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|